CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

Yuyi Wang,1,* Li Tu,1,* Chi Du,2,* Xiaoxiao Xie,1 Yanyang Liu,1 Jiantao Wang,1 Zhixi Li,1 Ming Jiang,1 Dan Cao,1 Xi Yan,1 Feng Luo1 1Lung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:OncoTargets and Therapy
Subjects:
cancer stem-like cell
CXCR2
triple-negative breast cancer
marker
Online Access:https://www.dovepress.com/cxcr2-is-a-novel-cancer-stem-like-cell-marker-for-triple-negative-brea-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/cxcr2-is-a-novel-cancer-stem-like-cell-marker-for-triple-negative-brea-peer-reviewed-article-OTT

Similar Items